| Prevalence and predictors of Cisplatin-induced peripheral neuropathy at the kenyatta national hospital MS Ezzi, NA Othieno-Abinya, E Amayo, P Oyiro, A McLigeyo, RB Yatich, ... Journal of global oncology 5, 1-6, 2019 | 10 | 2019 |
| Developing clinical strength-of-evidence approach to define HIV-associated malignancies for cancer registration in Kenya A Korir, N Mauti, P Moats, MJ Gurka, G Mutuma, C Metheny, PM Mwamba, ... PloS one 9 (1), e85881, 2014 | 10 | 2014 |
| Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study A McLigeyo, J Rajab, P Oyiro, M Ezzi, Y Bett, M Ong’ondi, A Odhiambo, ... Bmc Cancer 22 (1), 128, 2022 | 6 | 2022 |
| Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course A McLigeyo, J Rajab, M Ezzi, P Oyiro, Y Bett, A Odhiambo, M Ong’ondi, ... Advances in Hematology 2020 (1), 7696204, 2020 | 4 | 2020 |
| Haematological parameters in chronic myeloid leukaemia as determinants of clinical manifestations in this disease. NA Othieno-Abinya, WO Mwanda, MD Maina, AO Odhiambo, SA Mwanzi, ... Journal of Clinical Oncology 34 (15_suppl), e18529-e18529, 2016 | 3 | 2016 |
| Exploring Occupational and Familial Risks for Chronic Myeloid Leukaemia NA Othieno-Abinya, WO Mwanda, JDM Maina, A Odhiambo, P Oyiro, ... Journal of US-China Medical Science 14, 31-35, 2017 | 2 | 2017 |
| Treatment failure with first line imatinib for patients with chronic myeloid leukaemia in Kenya vs high-income countries. AA Mcligeyo, N Abinya, SA Mwanzi, PO Oyiro, AO Odhiambo, MS Ezzi, ... Journal of Clinical Oncology 41 (16_suppl), e19068-e19068, 2023 | 1 | 2023 |
| Transmissible Agents, HIV, and Cancer PO Oyiro, N Roidad, M Monga, J Guilfoose, MA Fisher, SC Remick Global Perspectives on Cancer, 2015 | 1 | 2015 |
| Prevalence of musculoskeletal manifestations in post-acute COVID 19 patients and their quality-of-life at Kenyatta National Hospital, Nairobi, Kenya M Kiyiapi, O Oyoo, P Oyiro, F Wangai East African Medical Journal 101 (3), 6795-6806, 2024 | | 2024 |
| Clinicopathologic characteristics and treatment outcomes of pancreatic cancer patients at a tertiary referral hospital in Kenya SW Muchiri, EO Ogutu, PO Oyiro, L Aabakken ecancermedicalscience 18, 2024 | | 2024 |
| Report of a chronic myeloid leukemia registry in a low-and middle-income setting. NA Othieno-Abinya, W Mwanda, MC Mutebi, MF Nyangasi, V Mwenda, ... Journal of Clinical Oncology 41 (16_suppl), 7054-7054, 2023 | | 2023 |
| Efficacy and safety of ponatinib in management of chronic myeloid leukaemia: Experience from Kenya. NA Othieno-Abinya, AA Mcligeyo, PO Oyiro, AO Odhiambo, MS Ezzi, ... Journal of Clinical Oncology 41 (16_suppl), e19067-e19067, 2023 | | 2023 |
| Factors other than sheer numbers of blood cells in circulation may be responsible for clinical presentations in chronic myeloid leukaemia. NA Othieno-Abinya, AO Odhiambo, MS Ezzi, PO Oyiro Journal of Clinical Oncology 38 (15_suppl), e19527-e19527, 2020 | | 2020 |
| Research Article Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course A McLigeyo, J Rajab, M Ezzi, P Oyiro, Y Bett, A Odhiambo, M Ong’ondi, ... | | 2020 |
| Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course. J Rajab, M Ezzi, A Odhiambo, M Gatua, NAO Abinya, A McLigeyo, P Oyiro, ... University of Nairobi, 2020 | | 2020 |
